semaglutide effect on brain Recurrent Idiopathic Intracranial Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema New study finds semaglutide safe

19 December 2024: FDA confirms tirzepatide shortage is still over, gives compounders a grace period Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s

Recognizing GLP is crucial because traditional language intervention strategies often fail for gestalt processors

Peptides like this one are fragile molecules, and an injectable, subcutaneous form is generally the most predictable way to deliver a known, stable amount into the body

Reduced gut motility is a known risk factor for conditions like: SIBO (Small Intestinal Bacterial Overgrowth) IMO (Intestinal Methanogen Overgrowth) Both involve an overgrowth of microbes in the small intestine, where bacterial levels are usually lower

Most plans now require a 6 month documented history of lifestyle intervention before approving a prior authorization

It is especially relevant for patients whose body composition concerns center around abdominal fat accumulation